Curtis L. Cooper
Expertise in
8
conditions

Curtis L. Cooper

501 Smyth Road, 
Ottawa, ON, CA 
Expertise in
8
conditions
501 Smyth Road, 
Ottawa, ON, CA 

Overview

Curtis Cooper practices practicing medicine in Ottawa, Canada.

Mr. Cooper is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, HIV/AIDS, Heart Transplant, and Liver Transplant.

He is actively involved in clinical research, co-authoring 339 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

501 Smyth Road, Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch Followed by Ledipasvir-Sofosbuvir HCV Therapy in HIV-HCV Co-Infection: A CIHR Canadian HIV Trials Network-Gilead Pilot Trial Proposal
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch Followed by Ledipasvir-Sofosbuvir HCV Therapy in HIV-HCV Co-Infection: A CIHR Canadian HIV Trials Network-Gilead Pilot Trial Proposal
Enrollment Status: Completed
Publish Date: November 14, 2022
Intervention Type: Drug
Study Drugs: Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide, Ledipasvir, Sofosbuvir
Study Phase: Phase 3
Immunogenicity Outcomes in People Living With HIV Following Vaccination for COVID-19 (HIV-COV)
Immunogenicity Outcomes in People Living With HIV Following Vaccination for COVID-19 (HIV-COV)
Enrollment Status: Unknown
Publish Date: October 15, 2021
Intervention Type: Biological
Pilot Evaluation of the Influence of ABT450r, Ombitasvir, Dasabuvir +/- Ribavirin HCV Therapy on Insulin Resistance and Lipid Profile
Pilot Evaluation of the Influence of ABT450r, Ombitasvir, Dasabuvir +/- Ribavirin HCV Therapy on Insulin Resistance and Lipid Profile
Enrollment Status: Completed
Publish Date: August 13, 2019
Intervention Type: Drug
Study Phase: Phase 4
Improving Treatment and Liver Fibrosis Outcomes With Metformin in HCV-HIV Co-infected and HCV Mono-infected Patients With Insulin Resistance.
Improving Treatment and Liver Fibrosis Outcomes With Metformin in HCV-HIV Co-infected and HCV Mono-infected Patients With Insulin Resistance.
Enrollment Status: Withdrawn
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

337 Total Publications

Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.
Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.
Journal: AIDS research and human retroviruses
Published: July 24, 2026

Frequently Asked Questions about Curtis L. Cooper

Is Curtis L. Cooper a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Curtis L. Cooper is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Curtis L. Cooper participate in research or clinical trials?

Yes. Curtis L. Cooper has published 337 articles and abstracts on conditions like Hepatitis. You can view a list of Curtis L. Cooper's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cooper's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile